A substance that is being studied in the treatment of cancer. It binds to certain immune cells and may suppress cancer growth. … [Read more...]
C
CDC7 kinase inhibitor BMS-863233
An orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor BMS-863233 binds to … [Read more...]
CDC7 kinase inhibitor NMS-1116354
An orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor NMS-1116354 binds to … [Read more...]
CDDO
A substance being studied in the treatment of some types of cancer. CDDO may block enzymes involved in inflammation and cancer growth. It is a type of … [Read more...]
CDK inhibitor AT7519M
A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to divide. It is a type of … [Read more...]
CDK inhibitor SCH 727965
A substance being studied in the treatment of advanced melanoma (a type of skin cancer) and other types of cancer. It blocks cell division and may cause cancer … [Read more...]
CDK inhibitor SNS-032
A 2-aminothiazole-derived, small-molecule cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. CDK inhibitor SNS-032 selectively … [Read more...]
CDK2 / TRKA inhibitor PHA-848125 AC
An orally bioavailable inhibitor of cyclin-dependent kinases (CDKs) and thropomyosin receptor kinase A (TRKA), with potential antineoplastic activity. CDK2/TRKA … [Read more...]
CDK4 inhibitor P1446A-05
A protein kinase inhibitor specific for the cyclin-dependent kinase 4 (CDK4) with potential antineoplastic activity. CDK4 inhibitor P1446A-05 specifically … [Read more...]
CDKI AT7519
An orally bioavailable small molecule with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases (CDKs), which … [Read more...]